Allscripts (MDRX) Misses Q1 EPS by 1c, Affirms Outlook

Allscripts (NASDAQ: MDRX) reported Q1 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $518.6 million versus the consensus estimate of $530.48 million.

Allscripts affirms the following financial outlook for 2018

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c